Credit Suisse Ag Cellectis S.A. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

A detailed history of Credit Suisse Ag transactions in Cellectis S.A. stock. As of the latest transaction made, Credit Suisse Ag holds 1,438,255 shares of CLLS stock, worth $2.69 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,438,255

Previous 1,438,255 -0.0%

Holding current value

$2.69 Million

Previous $4.43 Million 13.95%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$2.39 - $4.93 $7,958 - $16,416	-3,330 Reduced 0.23%	1,438,255 $4.07 Million
Q1 2022 May 16, 2022	BUY	$3.45 - $8.77 $822,079 - $2.09 Million	238,284 Added 19.8%	1,441,585 $6.55 Million
Q4 2021 Feb 14, 2022	BUY	$8.01 - $12.84 $26,441 - $42,384	3,301 Added 0.28%	1,203,301 $9.77 Million
Q3 2021 Nov 12, 2021	SELL	$11.94 - $16.09 $11 - $16	-1 Reduced -0.0%	1,200,000 $15.1 Million
Q2 2021 Aug 16, 2021	SELL	$14.36 - $20.93 $5,112 - $7,451	-356 Reduced 0.03%	1,200,001 $18.6 Million
Q1 2021 May 14, 2021	SELL	$18.19 - $33.25 $181 - $332	-10 Reduced -0.0%	1,200,357 $24.3 Million
Q4 2020 Feb 12, 2021	BUY	$15.87 - $31.64 $7.94 Million - $15.8 Million	500,367 Added 71.48%	1,200,367 $32.5 Million
Q2 2020 Aug 12, 2020	BUY	$8.21 - $21.02 $1.97 Million - $5.04 Million	239,971 Added 52.16%	700,000 $12.5 Million
Q1 2020 May 13, 2020	SELL	$7.81 - $18.82 $37,441 - $90,223	-4,794 Reduced 1.03%	460,029 $4.23 Million
Q4 2019 Feb 12, 2020	BUY	$9.73 - $19.31 $46,840 - $92,958	4,814 Added 1.05%	464,823 $7.96 Million
Q3 2019 Nov 12, 2019	SELL	$10.15 - $16.89 $2,639 - $4,391	-260 Reduced 0.06%	460,009 $4.78 Million
Q2 2019 Aug 14, 2019	BUY	$14.6 - $20.6 $1,883 - $2,657	129 Added 0.03%	460,269 $7.18 Million
Q1 2019 May 14, 2019	SELL	$15.53 - $19.75 $2,562 - $3,258	-165 Reduced 0.04%	460,140 $8.44 Million
Q4 2018 Feb 13, 2019	BUY	$15.58 - $28.41 $617,560 - $1.13 Million	39,638 Added 9.42%	460,305 $7.66 Million
Q3 2018 Nov 13, 2018	BUY	$25.99 - $30.6 $919,084 - $1.08 Million	35,363 Added 9.18%	420,667 $11.9 Million
Q2 2018 Aug 14, 2018	SELL	$27.78 - $38.53 $1.81 Million - $2.51 Million	-65,194 Reduced 14.47%	385,304 $10.9 Million
Q1 2018 May 15, 2018	BUY	$27.78 - $35.19 $4.46 Million - $5.65 Million	160,581 Added 55.39%	450,498 $14.2 Million
Q4 2017 Feb 14, 2018	BUY	$23.33 - $35.01 $3.5 Million - $5.25 Million	149,917 Added 107.08%	289,917 $8.45 Million
Q3 2017 Nov 14, 2017	BUY	$21.65 - $32.18 $1.73 Million - $2.57 Million	80,000 Added 133.33%	140,000 $3.98 Million
Q2 2017 Aug 14, 2017	BUY	N/A	60,000	60,000 $1.55 Million

Others Institutions Holding CLLS

# of Institutions

Shares Held

11.2M

Call Options Held

5.9K

Put Options Held

1.4K

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $85.1M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account